{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:10Z","timestamp":1791052090782,"version":"4.1.0"},"reference-count":27,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1517\/14740338.2013.780025","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T08:27:54Z","timestamp":1363681674000},"page":"309-319","source":"Crossref","is-referenced-by-count":15,"title":["Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis"],"prefix":"10.1517","volume":"12","author":[{"given":"Warren","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shau Yu","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Munera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R","family":"Ripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Maibach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2013,3,19]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-009-0075-9"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.08.019"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.574689"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4510-771"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(01)00167-1"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp070554"},{"key":"CIT0007","unstructured":"Butrans [package insert]. Purdue Pharma LP, Stamford, CT; 2011"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.005"},{"key":"CIT0009","unstructured":"Climara Pro [package insert]. Bayer HealthCare Pharmaceuticals, Inc, Wayne NJ; 2007"},{"key":"CIT0010","unstructured":"Duragesic [package insert]. Janssen Pharmaceuticals, Inc, Titusville, NJ; 2011"},{"key":"CIT0011","unstructured":"Daytrana [package insert]. Noven Therapeutics, LLC, Miami, FL; 2010"},{"key":"CIT0012","unstructured":"Emsam [package insert]. Somerset Pharmaceuticals, Inc, Morgantown, WV; 2009"},{"key":"CIT0013","unstructured":"Estraderm [package insert]. Novartis Pharmaceuticals Corp, East Hanover, NJ; 2005"},{"key":"CIT0014","unstructured":"Exelon [package insert]. Novartis Pharmaceuticals Corp, East Hanover, NJ; 2010"},{"key":"CIT0015","unstructured":"Flector [package insert]. King Pharmaceuticals, Inc, Bristol, TN; 2011"},{"key":"CIT0016","unstructured":"Menostar [package insert]. Bayer HealthCare Pharmaceuticals, Inc, Wayne, NJ; 2007"},{"key":"CIT0017","unstructured":"Ortho Evra [package insert]. Ortho-McNeil-Janssen Pharmaceuticals, Inc, Raritan, NJ; 2011"},{"key":"CIT0018","unstructured":"Oxytrol [package insert]. Watson Pharma, Inc, Morristown, NJ; 2010"},{"key":"CIT0019","unstructured":"Sancuso [package insert]. ProStraken, Inc, Bedminster, NJ; 2008"},{"key":"CIT0020","unstructured":"Synera [package insert]. Zars Pharma, Inc, Salt Lake City, UT; 2010"},{"key":"CIT0021","unstructured":"Butrans. Physicians' desk reference 2011. 65th edition. PDR Network, LLC, Montvale, NJ; 2010. p. 2864-73"},{"key":"CIT0022","unstructured":"Butrans. Physicians' desk reference 2012. 66th edition. PDR Network LLC, Montvale, NJ; 2011. p. 2495-504"},{"key":"CIT0023","unstructured":"Duragesic. Physicians' desk reference 1992. 46th edition. Medical Economics Data, Montvale, NJ; 1992. p. 1133-6"},{"key":"CIT0024","unstructured":"Duragesic. Physicians' desk reference 2012. 66th edition. PDR Network LLC, Montvale, NJ; 2011. p. 1489-96"},{"key":"CIT0025","unstructured":"Duragesic. Physicians' desk reference 2004. 58th edition. Thompson PDR, Montvale, NJ; 2004. p. 1751-5"},{"key":"CIT0026","unstructured":"Catapres-TTS. [package insert]. Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT; 2012"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.4065\/70.6.581"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2013.780025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T08:59:12Z","timestamp":1481619552000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2013.780025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,19]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,7]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1517\/14740338.2013.780025"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2013.780025","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,19]]}}}